EG icon

Everest Group

333.65 USD
+3.02
0.91%
At close Updated Sep 17, 4:00 PM EDT
Pre-market
After hours
333.65
0.00
0%
1 day
0.91%
5 days
-2.14%
1 month
0.51%
3 months
0.19%
6 months
-8.6%
Year to date
-8.17%
1 year
-13.91%
5 years
62.79%
10 years
89.51%
 

About: Everest Group Ltd is a Bermuda-based reinsurance and insurance organization. It operates in the Reinsurance and Insurance business. It is a financial services institution focused on diversifying its portfolio and geographic presence. Through direct and indirect subsidiaries operating in the U.S. and internationally. The Insurance operation writes property and casualty insurance directly and through brokers, surplus lines brokers, and general agents within the U.S., Bermuda, Canada, Europe, and South America. The Company conducts business through two reportable segments, Reinsurance and Insurance.

Employees: 2,428

0
Funds holding %
of 7,463 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

44% more call options, than puts

Call options by funds: $96.6M | Put options by funds: $67M

13% more repeat investments, than reductions

Existing positions increased: 262 | Existing positions reduced: 231

13% more funds holding in top 10

Funds holding in top 10: 8 [Q1] → 9 (+1) [Q2]

3.05% more ownership

Funds ownership: 90.84% [Q1] → 93.89% (+3.05%) [Q2]

4% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 78

1% less funds holding

Funds holding: 667 [Q1] → 662 (-5) [Q2]

4% less capital invested

Capital invested by funds: $14.2B [Q1] → $13.6B (-$586M) [Q2]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$287
14% downside
Avg. target
$367
10% upside
High target
$416
25% upside

6 analyst ratings

positive
33%
neutral
50%
negative
17%
Wolfe Research
Tracy Benguigui
$287
Underperform
Initiated
16 Sep 2025
Citigroup
Matthew Heimermann
$362
Neutral
Initiated
13 Aug 2025
Keefe, Bruyette & Woods
Meyer Shields
$416
Outperform
Maintained
6 Aug 2025
Wells Fargo
Elyse Greenspan
$371
Equal-Weight
Maintained
4 Aug 2025
UBS
$370
Neutral
Maintained
9 Jul 2025

Financial journalist opinion

Based on 10 articles about EG published over the past 30 days

Neutral
PRNewsWire
11 hours ago
Persistent Awarded 'Growth Honor of the Year' at 2025 Everest Group Elevate Honors
Reflects consistent revenue growth and industry-defining performance among global peers SANTA CLARA, Calif. and PUNE, India , Sept.
Persistent Awarded 'Growth Honor of the Year' at 2025 Everest Group Elevate Honors
Positive
Zacks Investment Research
yesterday
Here's Why Everest Group (EG) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Everest Group (EG) is a Strong Value Stock
Negative
Seeking Alpha
14 days ago
Everest Group: Progress Despite Pricing Fears
Everest shares have underperformed given concerns about reserves and pricing trends. While pricing caps margin upside, we are not seeing activity that will pressure margins. Everest is meaningfully shifting its exposures, which should support improved underwriting results with Q3 likely to be strong.
Everest Group: Progress Despite Pricing Fears
Neutral
GlobeNewsWire
15 days ago
Medidata Secures a Leader Position in Everest Group's PEAK Matrix® Assessment for eCOA, Driving the New Patient Experience Forward
Medidata eCOA was the highest Leader recognized in the evaluation, supporting over 1M+ patients and reducing study build timeline by up to 50% compared to the industry standard Medidata eCOA was the highest Leader recognized in the evaluation, supporting over 1M+ patients and reducing study build timeline by up to 50% compared to the industry standard
Medidata Secures a Leader Position in Everest Group's PEAK Matrix® Assessment for eCOA, Driving the New Patient Experience Forward
Neutral
GlobeNewsWire
15 days ago
YPrime Named a Leader in Everest Group's 2025 eCOA PEAK Matrix® Assessment
YPrime, a proven leader in clinical trial technology, today announced it has been recognized as a Leader in the Everest Group's Life Sciences Electronic
YPrime Named a Leader in Everest Group's 2025 eCOA PEAK Matrix® Assessment
Positive
Zacks Investment Research
19 days ago
Everest Group (EG) Up 1.2% Since Last Earnings Report: Can It Continue?
Everest Group (EG) reported earnings 30 days ago. What's next for the stock?
Everest Group (EG) Up 1.2% Since Last Earnings Report: Can It Continue?
Neutral
Business Wire
20 days ago
eClerx Recognized as a Leader & Star Performer in Everest Group's Capital Markets Operations Services PEAK Matrix® 2025
NEW YORK--(BUSINESS WIRE)-- #25years--eClerx Recognized as a Leader & Star Performer in Everest Group's Capital Markets Operations Services PEAK Matrix® 2025.
eClerx Recognized as a Leader & Star Performer in Everest Group's Capital Markets Operations Services PEAK Matrix® 2025
Positive
Zacks Investment Research
20 days ago
Why Everest Group (EG) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Everest Group (EG) is a Top Value Stock for the Long-Term
Neutral
Business Wire
28 days ago
Everest Expands Board of Directors with Appointment of Laura Hay
HAMILTON, Bermuda--(BUSINESS WIRE)--Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing best-in-class property, casualty, and specialty reinsurance and insurance solutions, today announced the appointment of Laura Hay as an independent, non-executive member of its Board of Directors. “Laura brings an unprecedented level of experience dealing with the complex risk, regulatory, capital market and accounting issues inherent in a global insurance platform,” said John Graf, Everes.
Everest Expands Board of Directors with Appointment of Laura Hay
Positive
Zacks Investment Research
29 days ago
Everest Group Trades Below 50-Day SMA: How to Play the Stock?
EG gains from global growth, portfolio strength and a solid balance sheet, but faces weak ROE and catastrophe exposure.
Everest Group Trades Below 50-Day SMA: How to Play the Stock?
Charts implemented using Lightweight Charts™